NI-0101 has been proved effective in lipopolysaccharide-treated healthy volunteers [24]; nonetheless, recent clinical findings suggest that to cure RA, inhibition of TLR4 alone is not sufficient [25]. Here, TLR4 is linked to rheumatoid arthritis.